Cargando…
Immunotherapy Strategies for Gastrointestinal Stromal Tumor
SIMPLE SUMMARY: Gastrointestinal stromal tumors (GIST) are the most common type of gastrointestinal sarcomas. Recent treatment advancements have led to a significant improvement in the survival of patients living with GIST. Nevertheless, patients with metastatic GIST will eventually require multiple...
Autores principales: | Arshad, Junaid, Costa, Philippos A., Barreto-Coelho, Priscila, Valdes, Brianna Nicole, Trent, Jonathan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306810/ https://www.ncbi.nlm.nih.gov/pubmed/34298737 http://dx.doi.org/10.3390/cancers13143525 |
Ejemplares similares
-
Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021) -
Gastrointestinal stromal tumor and its targeted therapeutics
por: Dupart, Jheri, et al.
Publicado: (2011) -
Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules
por: Vallilas, Christos, et al.
Publicado: (2021) -
Gastrointestinal stromal tumor: Role of surgery and immunotherapy
por: Bhatnagar, Sushmita N.
Publicado: (2010) -
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis
por: Espejo-Freire, Andrea P., et al.
Publicado: (2021)